NHS England and the U.K. pharmaceutical industry have kicked off talks about drug pricing for the next four years, PMLiVE reports.
NHS England Chief Executive Simon Stevens said Thursday that the department would enter Pharmaceutical Price Regulation Scheme (PPRS) talks in “good faith” with the ultimate goal of recording a “triple win” for pharma, NHS and patients.
“Unlike the U.S. president, I don’t think you’ll find the British prime minister accusing the pharmaceutical industry of getting away with murder,” Stevens said.
According tot he report, the PPRS talks will continue through 2018 to reach an agreement by December. The deal would go into effect January 2019.
To read the full report on PMLiVE, click here.